Validated sandwich ELISA for the quantification of von Willebrand factor in rabbit plasma

Biomarker Insights

Volumn 2010, Issue 5, 2010, Pages 119-127

  Smith, Brendon W ^a,b   Strakova, Jana ^a,b   King, Jennifer L ^b   Erdman, John W ^a,c   O'Brien, William D ^a,b,d  

^a Division of Nutritional Sciences   (United States)

^b Bioacoustics Research Laboratory   (United States)

^c Department of Food Science and human nutrition ^*  (United States)

^d University of Illinois at Urbana Champaign   (United States)

Author keywords

Atherosclerosis; Biomarkers; Endothelium; Enzyme linked immunosorbent assay; Rabbits; von Willebrand Factor

Indexed keywords

CHOLESTEROL; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; CALIBRATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DILUTION; ENZYME IMMUNOASSAY; FREEZE THAWING; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RABBIT; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SPIKE;

ORYCTOLAGUS CUNICULUS;

EID: 78650574443     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/BMI.S6051     Document Type: Article

References (21)

1. Lloyd-Jones DRJ, Adams TM, Brown M, et al. Heart disease and stroke statistics-update: a report from the American Heart Association. Circulation. 2010;121:e46-215.
2. Libby P. Infammation in atherosclerosis. Nature. 2002;420:868-874.
3. Hansson GK. Infammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
4. Mannucci PM. Treatment of von Willebrand's Disease. N Engl J Med. 2004;351:683-694.
5. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta. 2006;368:33-47.
6. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res. 1997;34:255-65.
7. Spiel AO, Gilbert JC, Jilma B. von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation. 2008;117: 1449-1459.
8. King JL, Miller RJ, Blue JP Jr, O'Brien WD Jr, Erdman JW Jr. Inadequate dietary magnesium intake increases atherosclerotic plaque development in rabbits. Nutr Res. 2009;29:343-349.
9. Smolec J, DeSilva B, Smith W, et al. Bioanalytical method validation for macromolecules in support of pharmacokinetic studies. Pharm Res. 2005;22: 1425-1431.
10. Findlay JW, Smith WC, Lee JW, et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal. 2000;21:1249-1273.
11. Bartlett A, Dormandy KM, Hawkey CM, Stableforth P, Voller A. Factor-VIII-related antigen: measurement by enzyme immunoassay. Br Med J. 1976;1:994-996.
12. de Meyer GR, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, Bult H. Intimal deposition of functional von Willebrand factor in atherogen-esis. Arterioscler Thromb Vasc Biol. 1999;19:2524-2534.
13. Benson RE, Catalfamo JL, Dodds WJ. A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor. J Lab Clin Med. 1992; 119:420-427.
14. Ghayour-Mobarhan M, Lamb DJ, Tavallaie S, Ferns GA. Relationship between plasma cholesterol, von Willebrand factor concentrations, extent of atherosclerosis and antibody titres to heat shock proteins-60, -65 and -70 in cholesterol-fed rabbits. Int J Exp Pathol. 2007;88:249-255.
15. Haghjooyjavanmard S, Nematbakhsh M, Monajemi A, Soleimani M. von Willebrand factor, C-reactive protein, nitric oxide, and vascular endothelial growth factor in a dietary reversal model of hypercholesterolemia in rabbit. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2008; 152:91-95.
16. Reed GF, Lynn F, Meade BD. Use of coeffcient of variation in assessing variability of quantitative assays. Clin Diagn Lab Immunol. 2002;9: 1235-1239.
17. FDA. Guidance for Industry: Bioanalytical Method Validation. 2001.
18. DeSilva B, Smith W, Weiner R, et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res. 2003;20:1885-1900.
19. O'Connell MA, Belanger BA, Haaland PD. Calibration and assay development using the four-parameter logistic model. Chemom Intell Lab Syst. 1993;20:97-114.
20. Findlay JW, Dillard RF. Appropriate calibration curve ftting in ligand binding assays. AAPS J. 2007;9:E260-267.
21. Lavergne JM, Piao YC, Ferreira V, Kerbiriou-Nabias D, Bahnak BR, Meyer D. Primary structure of the factor VIII binding domain of human, porcine and rabbit von Willebrand factor. Biochem Biophys Res Commun. 1993;194:1019-1024.